Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives. Quick Links Investor Presentation Responsibility News Portfolio Responsibility Report Annual Reports Leadership Governance SEC Filings Latest Press Releases August 22, 2023 Incyte to Present at Upcoming Investor Conferences August 1, 2023 Incyte Reports 2023 Second Quarter Financial Results and Provides Updates on Key Clinical Programs July 31, 2023 Replimune and Incyte Enter into Clinical Trial Collaboration and Supply Agreement to Evaluate RP1 and INCB99280 in Patients with Cutaneous Squamous Cell Carcinoma All press releases Latest Events Sep 14 2023 Sep 14 2023 Bank of America 2023 Global Healthcare Conference Click here for Webcast Sep 11 2023 Sep 11 2023 Morgan Stanley 21st Annual Global Healthcare Conference Click here for Webcast Sep 7 2023 Sep 7 2023 Wells Fargo 2023 Healthcare Conference Click here for Webcast All events
